4-Thiothymidine
Based on 1 Customer Validation
4-Thiothymidine is a thymidine analog with UVA photosensitizing properties. 4-Thiothymidine incorporates into the DNA of dividing cells via the thymidine kinase-mediated salvage pathway, replacing thymine and sensitizing cells to UVA irradiation, thereby inducing apoptosis. 4-Thiothymidine induces DNA damage upon UVA activation and inhibits DNA replication. 4-Thiothymidine is used in research related to non-melanoma skin malignancies such as squamous cell carcinoma.
For research use only. We do not sell to patients.
- Purity : 99.69%
- CAS No.: 7236-57-9
- Formula: C10H14N2O4S
- Molecular Weight:258.29
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Biological Activity
Description
In Vitro
4-Thiothymidine (S4TdR) (100 μM; 48 h) photoactivation does not significantly increase ROS production in HaCaT cells compared with UVA alone, and does not significantly increase UVA-induced single-strand breaks, guanine oxidation, or CPD formation[1].
4-Thiothymidine treatment (combined with UVA irradiation) induces pan-nuclear γ-H2AX staining in HaCaT cells, indicating replication inhibition rather than discrete focal double-strand breaks[1].
4‑Thiothymidine exhibits extremely potent cytotoxicity toward HR‑deficient xrcc2 hamster cells and XPF‑deficient UV41 cells under 0.1 kJ/m2 UVA conditions. S5‑(6‑4) T:T photoproducts are removed via nucleotide excision repair in HaCaT cells; these photoproducts are completely irreparable in XPA‑deficient XP12RO cells and exhibit significantly reduced repair capacity in CCRF‑CEM leukemia cells[1].
4-Thiothymidine efficiently generates singlet oxygen in O2-saturated acetonitrile solution with a quantum yield of 0.42[3].
4-Thiothymidine (100 μM; 48 h, combined with UVA irradiation) incorporates into the cellular DNA of HaCaT human keratinocytes and generates thietane/S5-(6-4) T:T photoproducts as well as DNA interstrand crosslinks[1].
4-Thiothymidine (100 μM; 24 h, combined with 10 kJ/m2 UVA irradiation) induces extensive apoptosis in SCC-15 cutaneous squamous cell carcinoma cells[2].
4-Thiothymidine (topical formulation; 5-8 h, combined with UVA irradiation) penetrates epidermal tissue, induces extensive apoptosis in ex vivo basal cell carcinoma and squamous cell carcinoma biopsy samples, and causes almost no damage to non-proliferating normal skin tissue[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HaCaT
-
Concentration:100 μM
-
Incubation Time:48 h
-
Result:Induced pan-nuclear γ-H2AX staining in most cells after 4 h of irradiation, consistent with inhibited replication.
-
Cell Line:SCC-15 human squamous cell carcinoma cells
-
Concentration:100 μM
-
Incubation Time:24 h
-
Result:Induced almost complete apoptosis in SCC-15 cells when combined with 10 kJ/m2 UV-A irradiation.
Chemical Information
-
CAS No. 7236-57-9
-
Appearance Solid
-
Molecular Weight 258.29
-
Formula C10H14N2O4S
-
Color Light yellow to light brown
-
SMILES
OC[C@@H]1[C@@H](O)C[C@H](N2C(NC(C(C)=C2)=S)=O)O1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
In Vitro:
DMSO : 116.67 mg/mL (451.70 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
PCNA Immunodetection Proliferation Assay
PCNA immunodetection measures proliferative activity by detecting proliferating cell nuclear antigen, a nuclear protein associated with DNA polymerase δ function and DNA replication. The assay readout is the proportion of PCNA-positive nuclei among total counted cells, but PCNA labeling is not identical to BrdU labeling because PCNA can mark late G1/early S-associated replication competence and may persist beyond active DNA synthesis depending on fixation and extraction conditions.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
-
Data Sheet (288 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.8716 mL | 19.3581 mL | 38.7162 mL | 96.7904 mL |
| 5 mM | 0.7743 mL | 3.8716 mL | 7.7432 mL | 19.3581 mL | |
| 10 mM | 0.3872 mL | 1.9358 mL | 3.8716 mL | 9.6790 mL | |
| 15 mM | 0.2581 mL | 1.2905 mL | 2.5811 mL | 6.4527 mL | |
| 20 mM | 0.1936 mL | 0.9679 mL | 1.9358 mL | 4.8395 mL | |
| 25 mM | 0.1549 mL | 0.7743 mL | 1.5486 mL | 3.8716 mL | |
| 30 mM | 0.1291 mL | 0.6453 mL | 1.2905 mL | 3.2263 mL | |
| 40 mM | 0.0968 mL | 0.4840 mL | 0.9679 mL | 2.4198 mL | |
| 50 mM | 0.0774 mL | 0.3872 mL | 0.7743 mL | 1.9358 mL | |
| 60 mM | 0.0645 mL | 0.3226 mL | 0.6453 mL | 1.6132 mL | |
| 80 mM | 0.0484 mL | 0.2420 mL | 0.4840 mL | 1.2099 mL | |
| 100 mM | 0.0387 mL | 0.1936 mL | 0.3872 mL | 0.9679 mL |